Volume 17 Supplement 1
Cardiac and skeletal muscle abnormality in taurine transporter-knockout mice
© Azuma et al; licensee BioMed Central Ltd. 2010
Published: 24 August 2010
Taurine, a sulfur-containing β-amino acid, is highly contained in heart and skeletal muscle. Taurine has a variety of biological actions, such as ion movement, calcium handling and cytoprotection in the cardiac and skeletal muscles. Meanwhile, taurine deficiency leads various pathologies, including dilated cardiomyopathy, in cat and fox. However, the essential role of taurine depletion on pathogenesis has not been fully clarified. To address the physiological role of taurine in mammalian tissues, taurine transporter-(TauT-) knockout models were recently generated. TauTKO mice exhibited loss of body weight, abnormal cardiac function and the reduced exercise capacity with tissue taurine depletion. In this chapter, we summarize pathological profile and histological feature of heart and skeletal muscle in TauTKO mice.
Taurine is a most abundant free amino acid in mammalian tissues with an intracellular concentration of 5-20 µmol/g wet weight [1, 2]. A number of evidences revealed that taurine is a cytoprotective agent. Supplementation of taurine is effective to a variety of disorders, such as cardiovascular diseases, skeletal muscle disorders, etc. Meanwhile, taurine deficiency related to some kinds of pathophysiological conditions in cats and foxes, such as dilated cardiomyopathy, retinal degradation and reproduction[3–5].
Taurine transporter (TauT; SLC6a6) is a sodium and chloride ion-dependent transporter, and is expressed ubiquitously in mammalian tissues . Since the capacity to synthesize taurine in most tissues, such as heart and skeletal muscle, is limited, maintenance of the large intracellular taurine pool may depend upon uptake of the amino acid from extracellular space via TauT. This transport process requires the accumulation of taurine against a substantial concentration gradient, as the concentration of taurine is 100 fold less in the plasma (20-100 µM) than in the tissues.
Recently, transgenic mice lacking TauT gene have been generated by two groups [7, 8]. A variety of disorders has been reported in various tissues, such as eye, kidney, heart, muscle, etc., accompanied with drastic taurine deficiency in TauTKO mice [7–10]. In this chapter, we report the phenotype of TauTKO mice and discuss the role of taurine deficiency in hearts and skeletal muscles.
Analysis of taurine transporter knockout mice
In our TauTKO mice, targeting construct for generation of transgenic mice was designed to replace exons 2–4 of the TauT gene with a cassette containing neomycin-resistance gene . While a truncated TauT mRNA lacking exon 2-4 was detected in TauTKO tissues, taurine influx was eliminated in the cells isolated from TauTKO mice, indicating loss of taurine transport activity in TauTKO mice. Tissue taurine level is severely decreased in several tissues. Especially, cardiac taurine could not be detected in TauTKO mice, and skeletal muscle taurine level is decreased by 96% in TauTKO mice compared with wild-type mice. Similarly, in another TauTKO mouse model which was reported by Heller-Stilb et al, is lacking exon 2 of TauT gene, and taurine level in skeletal and cardiac muscles was decreased by about 98%, while taurine level in brain, kidney and liver is decreased by 70-90 % compared to wild-type mice . These data illustrate that maintenance of intracellular taurine pool in cardiac and skeletal muscle is extremely dependent upon taurine transport activity.
TauTKO mice exhibited a lower body weight than their control littermates. Furthermore, knocking out TauT causes a decrease in tissue weight, such as heart, skeletal muscle, brain etc [7, 8]. Food and water intake were identical in the TauTKO and control mice.
Cardiac Phenotype of TauTKO mice
Oral supplementation of taurine is effective to animals and human patients with congestive heart failure and cardiomyopathy [11, 12], indicating that taurine would play an important role in cardiac homeostasis and cardioprotection against pathological stress. It has been reported that taurine-deficient diet impaired cardiac function and led to dilated cardiomyopathy in cat and fox, which have very low capacity of taurine synthesis [3, 13]. Furthermore, drug-induced taurine deficiency by the inhibition of taurine uptake using guanidinoethane sulfonate (GES) or β-alanine led to some cardiac defects in mice or rats [11, 14].
Echocardiographic analysis of young and old TauTKO mice
On the other hand, Warskulat et al. reported that TauTKO mice exhibited normal cardiac function . These inconsistent results between two TauTKO models may be due to the difference of genetic background, since the difference of inbred strains affects the cardiovascular phenotypes and susceptibilities against pathological stressors in mice . We used mice which backcrossed at least 4 times into C57BL/6 line to minimize genetic differences, while Warskulat et al. reported the use of F2 mixed C57BL/6 amd 129/SvJ strains. Meanwhile, Warskulat et al. also reported that biomarker genes for heart failure, including ANP, BNP and CARP, are upregulated in TauTKO hearts consistent with our TauTKO model . Furthermore, they also demonstrated that the TauTKO hearts showed a switch from alpha-actin 1 (skeletal muscle type) to alpha-actin 2 (smooth muscle type) expression . These data suggest that other TauTKO mice (Warskulat et al) may have the aptitude toward heart failure, and hearts may be more susceptible to exogenous stresses in TauTKO mice.
Histological analysis revealed that TauTKO mice undergo ventricular remodeling, characterized by dilated ventricles and reductions in ventricular wall thickness . Furthermore, cross sectional area of ventricular cardiomyocytes was decreased in TauTKO hearts, implying the importance of taurine for cell size. Surprisingly, cardiac fibrosis was not observed in TauTKO heart. Transition electron microscopic analysis demonstrated that TauTKO hearts exhibited significant ultrastructural damage of myofilament and mitochondria. Furthermore, another important feature of TauTKO mice is the presence of autophagosome containing mitochondria. Autophagy is a biological process, in which cells degrade and recycle intracellular macromolecules and organelles. It is considered to represent a cellular adaptation to ensure survival, as injured and potentially damaging organelles are targeted for elimination. There are several triggers of mitochondrial autophagy, such as mtDNA damage, lipid peroxidation and the mitochondrial permeability transition [18–20]. Thus, the triggers themselves might provide useful information on the pathology that is occurring in the taurine knockout heart.
Phenotype of exercise capacity and skeletal muscle
Taurine is well known to modulate ion movement and play a role in the excitation-contraction coupling mechanism in skeletal muscle , 22. It has been reported that supplementation of taurine improved exercise capacity in rats and attenuated the exercise-induced oxidative injury [23, 24]. However, the effect of taurine deficiency on the exercise has been unclear. It has been reported that supplementation of GES to decrease in taurine content in muscles reduced force output and increased the endurance of skeletal muscles in rats . However, since GES itself directly increases susceptibility to Ca2+ on isolated muscle skinned fiber, the pharmacological action of GES must influence to the experiments using taurine depleted animal models .
In TauTKO mice, weight-loaded swimming test revealed that exercise endurance time was severely reduced compared to wild-type mice (118 ± 2.3 min in wild-type vs 10 ±2.5 min in TauTKO, p<0.01) . Additionally, forced treadmill test on uphill road also revealed that the duration of running time to exhaustion is reduced in TauTKO mice (49.0±11.0 min in wild-type vs 14.8±9.2 min in TauTKO, p<0.01). Warskulat et al. have also reported that total running distance to exhaustion on the treadmill is reduced by more than 80% in TauTKO mice . These data indicate that taurine deficiency may reduce muscle function in skeletal muscles. Moreover, Warskulat et al. demonstrated that X-ray studies of the skeleton did not reveal morphological disorders in TauTKO mice, indicating that skeletal muscle abnormalities may be associated with the reduction of exercise capacity in TauTKO mice.
TauTKO mice displayed the dilated cardiomyopathy, consistent with the phenotype of taurine-depleted cats. These data illustrate that taurine depletion is an independent etiology of cardiomyopathy. This model will provide benefits to find the molecular mechanism underlying taurine-depleted cardiomyopathy. Furthermore, lacking TauT results in aging-dependent cardiac dysfunction, indicating that taurine deficient hearts might be less able to tolerate aging. Aging-dependent disorders have been reported in several tissues of TauTKO mice, including visual, auditory, olfactory and renal dysfunctions and hepatitis [10, 27, 28]. Taurine deficiency i likely to increase susceptibility against stress, such as oxidative stress, which in turn causes to accelerated aging.
This study was supported in part by a Grants-in-Aid from the Ministry of Health, Labor and Welfare and from the Ministry of Education, Science, Sports and Culture of Japan. This study was also partly granted by Taisho Pharmaceutical Ltd.
This article has been published as part as part of Journal of Biomedical Science Volume 17 Supplement 1, 2010: Proceedings of the 17th International Meeting of Taurine. The full contents of the supplement are available online at http://www.jbiomedsci.com/supplements/17/S1.
- Chapman RA, Suleiman MS, Earm YE: Taurine and the heart. Cardiovasc Res. 1993, 27: 358-63. 10.1093/cvr/27.3.358.View ArticlePubMedGoogle Scholar
- Chesney RW: Taurine: its biological role and clinical implications. Adv Pediatr. 1985, 32: 1-42.PubMedGoogle Scholar
- Pion PD, Kittleson MD, Rogers QR, Morris JG: Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science. 1987, 237: 764-8. 10.1126/science.3616607.View ArticlePubMedGoogle Scholar
- Hayes KC, Carey RE, Schmidt SY: Retinal degeneration associated with taurine deficiency in the cat. Science. 1975, 188: 949-51. 10.1126/science.1138364.View ArticlePubMedGoogle Scholar
- Sturman JA: Dietary taurine and feline reproduction and development. J Nutr. 1991, 121: S166-70.PubMedGoogle Scholar
- Uchida S, Kwon HM, Yamauchi A, Preston AS, Marumo F, Handler JS: Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl(-)-dependent taurine transporter that is regulated by hypertonicity. Proc Natl Acad Sci U S A. 1992, 89: 8230-4. 10.1073/pnas.89.17.8230.PubMed CentralView ArticlePubMedGoogle Scholar
- Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M, Okabe M: Taurine depletion caused by knocking out the taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol. 2008, 44: 927-37. 10.1016/j.yjmcc.2008.03.001.View ArticlePubMedGoogle Scholar
- Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U, Haussinger D: Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. Faseb J. 2002, 16: 231-3.PubMedGoogle Scholar
- Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW, Molojavyi A, Heller-Stilb B, Schrader J, Haussinger D: Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. Faseb J. 2004, 18: 577-9.PubMedGoogle Scholar
- Warskulat U, Heller-Stilb B, Oermann E, Zilles K, Haas H, Lang F, Haussinger D: Phenotype of the taurine transporter knockout mouse. Methods Enzymol. 2007, 428: 439-58. full_text.View ArticlePubMedGoogle Scholar
- Takihara K, Azuma J, Awata N, Ohta H, Hamaguchi T, Sawamura A, Tanaka Y, Kishimoto S, Sperelakis N: Beneficial effect of taurine in rabbits with chronic congestive heart failure. Am Heart J. 1986, 112: 1278-84. 10.1016/0002-8703(86)90360-1.View ArticlePubMedGoogle Scholar
- Azuma J, Hasegawa H, Sawamura A, Awata N, Ogura K, Harada H, Yamamura Y, Kishimoto S: Therapy of congestive heart failure with orally administered taurine. Clin Ther. 1983, 5: 398-408.PubMedGoogle Scholar
- Moise NS, Pacioretty LM, Kallfelz FA, Stipanuk MH, King JM, Gilmour RF: Dietary taurine deficiency and dilated cardiomyopathy in the fox. Am Heart J. 1991, 121: 541-7. 10.1016/0002-8703(91)90724-V.View ArticlePubMedGoogle Scholar
- Lake N: Loss of cardiac myofibrils: mechanism of contractile deficits induced by taurine deficiency. Am J Physiol. 1993, 264: H1323-6.PubMedGoogle Scholar
- Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H: Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev. 2007, 12: 331-43. 10.1007/s10741-007-9034-1.View ArticlePubMedGoogle Scholar
- Barrick CJ, Rojas M, Schoonhoven R, Smyth SS, Threadgill DW: Cardiac response to pressure overload in 129S1/SvImJ and C57BL/6J mice: temporal- and background-dependent development of concentric left ventricular hypertrophy. Am J Physiol Heart Circ Physiol. 2007, 292: H2119-30. 10.1152/ajpheart.00816.2006.View ArticlePubMedGoogle Scholar
- Warskulat U, Andree B, Lusebrink J, Kohrer K, Haussinger D: Switch from actin alpha1 to alpha2 expression and upregulation of biomarkers for pressure overload and cardiac hypertrophy in taurine-deficient mouse heart. Biol Chem. 2006, 387: 1449-54. 10.1515/BC.2006.181.View ArticlePubMedGoogle Scholar
- Scherz-Shouval R, Elazar Z: ROS, mitochondria and the regulation of autophagy. Trends Cell Biol. 2007, 17: 422-7. 10.1016/j.tcb.2007.07.009.View ArticlePubMedGoogle Scholar
- Rodriguez-Enriquez S, He L, Lemasters JJ: Role of mitochondrial permeability transition pores in mitochondrial autophagy. Int J Biochem Cell Biol. 2004, 36: 2463-72. 10.1016/j.biocel.2004.04.009.View ArticlePubMedGoogle Scholar
- Dirks AJ, Hofer T, Marzetti E, Pahor M, Leeuwenburgh C: Mitochondrial DNA mutations, energy metabolism and apoptosis in aging muscle. Ageing Res Rev. 2006, 5 (z): 179-95. 10.1016/j.arr.2006.03.002.View ArticlePubMedGoogle Scholar
- Conte Camerino D, Tricarico D, Pierno S, Desaphy JF, Liantonio A, Pusch M, Burdi R, Camerino C, Fraysse B, De Luca A: Taurine and skeletal muscle disorders. Neurochem Res. 2004, 29: 135-42. 10.1023/B:NERE.0000010442.89826.9c.View ArticlePubMedGoogle Scholar
- De Luca A, Pierno S, Tricarico D, Desaphy JF, Liantonio A, Barbieri M, Camerino C, Montanari L, Camerino DC: Taurine and skeletal muscle ion channels. Adv Exp Med Biol. 2000, 483: 45-56. full_text.View ArticlePubMedGoogle Scholar
- Yatabe Y, Miyakawa S, Ohmori H, Mishima H, Adachi T: Effects of taurine administration on exercise. Adv Exp Med Biol. 2009, 643: 245-52. full_text.View ArticlePubMedGoogle Scholar
- Dawson R, Biasetti M, Messina S, Dominy J: The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids. 2002, 22: 309-24. 10.1007/s007260200017.View ArticlePubMedGoogle Scholar
- Hamilton EJ, Berg HM, Easton CJ, Bakker AJ: The effect of taurine depletion on the contractile properties and fatigue in fast-twitch skeletal muscle of the mouse. Amino Acids. 2006, 31: 273-8. 10.1007/s00726-006-0291-4.View ArticlePubMedGoogle Scholar
- Cuisinier C, Gailly P, Francaux M, Lebacq J: Effects of guandinoethane sulfonate on contraction of skeletal muscle. Adv Exp Med Biol. 2000, 483: 403-9. full_text.View ArticlePubMedGoogle Scholar
- Huang DY, Boini KM, Lang PA, Grahammer F, Duszenko M, Heller-Stilb B, Warskulat U, Haussinger D, Lang F, Vallon V: Impaired ability to increase water excretion in mice lacking the taurine transporter gene TAUT. Pflugers Arch. 2006, 451: 668-77. 10.1007/s00424-005-1499-y.View ArticlePubMedGoogle Scholar
- Warskulat U, Borsch E, Reinehr R, Heller-Stilb B, Monnighoff I, Buchczyk D, Donner M, Flogel U, Kappert G, Soboll S: Chronic liver disease is triggered by taurine transporter knockout in the mouse. Faseb J. 2006, 20: 574-6.PubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.